Tianzhi Yaocheng

天智药成科技（重庆）有限公司是一家专注于人工智能在New drug development领域应用的高科技企业。

Company Overview

• Established: January 3, 2023
• registered office: Phase 1, Standard Factory Building, Chongqing National Biomedical Industry Base, No. 28 Gaoxin Avenue, Jinfeng Town, Hi-Tech Zone, Chongqing, P.R. China
• authorized representative: Lau Choi-ping
• Type of company: Limited liability company (invested or controlled by natural persons)

Tianzhi PharmaTech (Chongqing) Co., Ltd. is committed to the use of artificial intelligence technology to promote the innovation and development of new drug research and development, with a strong R & D team and advanced technology platform.

Business

TIJI PharmaTech's business areas cover the following major areas:

• Technical Services and Development: Provide a full range of technical services, technology development, technology consulting, technology exchange, technology transfer, technology promotion and other technical support.
• Cloud computing and equipment services: It involves cloud computing equipment manufacturing, cloud computing equipment technical services, etc., providing powerful computing and data support for new drug R&D.
• Information Systems Integration and Software Development: Provides computer system services, information system integration services, AI application software development, AI basic software development, etc., and provides information technology solutions for new drug development.
• Medical research and experimental development: Focuses on medical research and trial development to drive innovation and progress in the development of new medicines.

Main products

The main products of TIJI PharmaTech areAI full-parameter druggability prediction platform(ADMET Drug Formulary Prediction Platform), which has the following features:

• powerful: It is able to correlate key parameters related to the structure and drugability of compounds, including absorption, distribution, metabolism, excretion, toxicity, and more than 160 other drugability parameters.
• Predictive accuracy: Based on the state-of-the-art graph neural network architecture and multiple molecular descriptors, we have created a prediction model with our own intellectual property rights to ensure the accuracy and reliability of the prediction.
• wide range of applications: It is applicable to all stages of seedling compound screening, lead compound optimization, preclinical development, and clinical trials, providing powerful data support for drug discovery and development.

core technology

Tianzhi PharmaTech's core technologies are mainly centered on the application of artificial intelligence in the field of new drug discovery and development, including but not limited to the following aspects:

• AI algorithms and models: The company has a professional AI algorithm team dedicated to developing and optimizing various AI algorithms and models to improve the efficiency and accuracy of new drug development.
• Big Data Processing and Analytics: The company has strong big data processing capabilities and is able to process and analyze tens of millions of data on various indicators of drug molecule durability, providing strong data support for new drug development.
• Cloud Computing and High Performance Computing: The company utilizes cloud computing and high-performance computing technologies to provide powerful computing and data storage support to accelerate the process of new drug development.

To summarize, Tianzhi PharmaTech (Chongqing) Co., Ltd. has significant advantages and strengths in the field of artificial intelligence new drug research and development, and is committed to promoting the innovation and progress of new drug research and development.